Amdocs Limited (DOX) To Go Ex-Dividend on March 31st

Amdocs Limited (NASDAQ:DOXGet Free Report) announced a quarterly dividend on Tuesday, February 3rd. Stockholders of record on Tuesday, March 31st will be given a dividend of 0.569 per share by the technology company on Friday, April 24th. This represents a c) dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date is Tuesday, March 31st. This is a 8.0% increase from Amdocs’s previous quarterly dividend of $0.53.

Amdocs has raised its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 14 years. Amdocs has a payout ratio of 29.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Amdocs to earn $6.82 per share next year, which means the company should continue to be able to cover its $2.27 annual dividend with an expected future payout ratio of 33.3%.

Amdocs Stock Down 2.2%

DOX stock opened at $64.32 on Friday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $6.94 billion, a PE ratio of 12.44, a PEG ratio of 1.14 and a beta of 0.42. Amdocs has a 1-year low of $63.33 and a 1-year high of $95.41. The business’s 50 day simple moving average is $71.46 and its 200 day simple moving average is $77.76.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the business earned $1.66 EPS. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, research analysts anticipate that Amdocs will post 6.21 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on DOX shares. Stifel Nicolaus dropped their price objective on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Barclays lowered their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Finally, Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Get Our Latest Analysis on Amdocs

Amdocs Company Profile

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Dividend History for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.